Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Pharmacokinetic Effect of Clarithromycin on the AUC0-12h of Linezolid in Multidrug-resistant and Extensively Drug-resistant Tuberculosis (MDR/XDR-TB) Patients

NCT01521364 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT01521364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01521364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Pharmacokinetic Effect of Clarithromycin on the AUC0-12h of Linezolid in Multidrug-resistant and Extensively Drug-resistant Tuberculosis (MDR/XDR-TB) Patients
Lead sponsor
University Medical Center Groningen
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2011
Completion date
November 30, 2012
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extensively drug-resistant tuberculosis, multidrug-resistant tuberculosis